What’s New









Alcon releases 5-year CyPass data

Stephen Lane, MD, shared full results from the post-approval COMPASS-XT study at the 2018 ESCRS meeting in Lisbon, Portugal. The long-term safety data offers new insights into Alcon’s decision to withdraw the CyPass microstent from global markets last month. Source: AAO



658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553